Creating a tool to help patients with acute myeloid leukemia make treatment decisions
Official title: Developing a Values Elicitation Tool to Improve Treatment Decision-Making in Acute Myeloid Leukemia
Funded at Univ of North Carolina Chapel Hill · NIH-11112298 · Data updated 2026-11-12
This study is creating a helpful tool called PRIME for people with acute myeloid leukemia (AML) to express what matters most to them in their treatment, so they can make better decisions with their doctors about their care.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | June 11, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $285,049 |
| NIH project number | 5K08CA273684-02 |
| Project ID | NIH-11112298 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with acute myeloid leukemia who are facing treatment decisions.
✕Less likely to help
Patients who are not diagnosed with acute myeloid leukemia or those who are not actively involved in treatment decision-making may not benefit from this research.
What this research studies
This research focuses on developing a tool called PRIME that helps patients with acute myeloid leukemia (AML) clarify their treatment preferences based on their personal values. By using a method called best-worst scaling, the tool generates a personalized report that assists patients and clinicians in shared decision-making. The goal is to improve the treatment decision-making process, especially as new therapies for AML become available. Patients will be engaged in discussions about what matters most to them, whether it's quality of life or survival.
Why it matters
Potential benefit: If successful, this research could empower patients with AML to make more informed treatment choices that align with their personal values.
How similar studies have gone: Previous research has shown promise in using values elicitation tools for patient decision-making, indicating that this approach could be effective.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Richardson, Daniel R — Univ of North Carolina Chapel Hill
- Study coordinator: Richardson, Daniel R
Related research
Other NIH-funded projects on the same topics.
-
Values tool to help AML patients choose treatments
A mentor-guided program is developing a values-based tool to help adults with acute myeloid leukemia choose treatment options that fit what matters most to them.
-
Targeting the SCP4 pathway in acute myeloid leukemia (AML)
Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.
-
Interferon-γ plus donor immune cells to fight AML/MDS after partial donor transplant
This project tests a therapy that adds a signaling protein, IFN-γ, with donor immune cells to help treat relapsed AML/MDS after a haploidentical stem cell transplant.
-
Targeting the protein housekeeping system in adult leukemia
Researchers are testing a new approach to treat acute myeloid leukemia by disrupting how AML cells manage their proteins, with the goal of helping patients live longer and healthier lives.
-
Understanding how epigenetic helper proteins drive AML and how to target them
A scientist team is studying how accessory proteins in gene-regulating complexes affect acute myeloid leukemia and whether they can be targeted for safer, more precise therapies.
-
Targeting FLVCR1-enabled choline use in a aggressive AML subtype
A new approach aims to block how a specific leukemia subtype (CG-AML) takes up choline to feed its growth, potentially slowing or stopping the disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.